I encourage you to tell a friend that 1 in 6 men will get prostate cancer and if someone you know is 40 or older, encourage them to get a simple PSA test done.
This year is particularly exciting due to the FDA approving a new drug, Provenge for late stage prostate cancer. more about Provenge
April 29, 2010 -- The FDA today approved Provenge, Dendreon Corp.'s individualized "vaccine" for the treatment of advanced prostate cancer.
The action comes more than three years after an FDA advisory panel recommended approval, declaring the immune therapy safe and effective. But FDA concerns over efficacy led the FDA to delay a decision until more data became available.
Provenge isn't your everyday vaccine. It's an immune therapy created by harvesting immune cells from a patient, genetically engineering them to fight prostate cancer, and then infusing them back into the patient.
For me what's exciting is this will give new energy to finding a cure for Prostate Cancer, hopefully in my lifetime.
Spread the word this Father's Day.